Skip to main content

Table 5 Studied variables of the subjects according to BMI categories

From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study

 

Body mass index (Kg/m2)

 

BMI < 25 n = 263

 

25 ≤ BMI < 30 n = 245

 

BMI ≥ 30 n = 113

Age (Years)

44.0 (SD = 13.6)

 

51.4 (SD = 10.4)

 

52.4 (SD = 10.2)

p

 

<0.001

 

0.765

 

Fasting glucose (mg/dl)

89.2 (SD = 10.9)

 

96.0 (SD = 15.8)

 

99.0 (SD = 14.8)

p

 

<0.001

 

0.132

 

Total cholesterol (mg/dl)

198.2 (SD = 40.5)

 

210.4 (SD = 39.5)

 

211.1 (SD = 37.1)

p

 

0.001

 

0.986

 

Triglycerides (mg/dl)

99.5 (SD = 55.1)

 

131.9 (SD = 81.0)

 

155.0 (SD = 120.8)

p

 

<0.001

 

0.032

 

HDL-cholesterol (mg/dl)

62.7 (SD = 15.3)

 

56.1 (SD = 13.8)

 

55.4 (SD = 13.3)

p

 

<0.001

 

0.913

 

Waist circumference (cm)

82.1 (SD = 9.7)

 

95.3 (SD = 8.9)

 

107.3 (SD = 11.0)

p

 

<0.001

 

<0.001

 

SBP (mm Hg)

121.9 (SD = 15.3)

 

128.6 (SD = 15.7)

 

134.4 (SD = 15.8)

p

 

<0.001

 

0.003

 

DBP (mm Hg)

74.3 (SD = 10.2)

 

78.6 (SD = 9.5)

 

80.1 (SD = 10.7)

p

 

<0.001

 

0.396

 

CVRSCORE (%)

1.0 (SD = 1.3)

 

1.8 (SD = 2.1)

 

1.8 (SD = 2.0)

p

 

<0.001

 

0.991

 

CVR REGICOR (%)

2.6 (SD = 1.7)

 

3.7 (SD = 2.5)

 

3.8 (SD = 2.4)

p

 

<0.001

 

0.964

 
  1. p ≤ 0.05 is considered to be statistically significant.
  2. Data are expressed as means (Standard Deviation).
  3. BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us